FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Yamanaka

Research Profile

Chemicals & Drugs

Phenomena

Phosphorylation

Living Beings

Genes & Molecular Sequences

Anatomy

Cells, Cultured

Concepts & Ideas

Kinetics

Physiology

Co-author Network

Publications

TOP 3
Hsu-Tso Ho; Li Fan; Beata Nowicka-Sans; Brian McAuliffe; Chang-Ben Li; Gregory Yamanaka; Nannan Zhou; Hua Fang; ira dicker; Richard A Dalterio; Yi-Fei Gong; Tao Wang; Zhiwei Yin; Yasutsugu Ueda; John Matiskella; John F Kadow; Paul Clapham; James Robinson; Richard J Colonno; Pin-Fang Lin
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
Pin-Fang Lin; Wade S Blair; Tao Wang; Timothy P Spicer; Qi Guo; Nannan Zhou; Yi-Fei Gong; Hwei-Gene Heidi Wang; Ronald Rose; Gregory Yamanaka; Brett Robinson; Chang-Ben Li; Robert Fridell; Carol Deminie; Gwendeline Demers; Zheng Yang; Lisa Zadjura; Nicholas A Meanwell; Richard J Colonno
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding.
S Levine; Dennis Hernandez; Gregory Yamanaka; Sharon Zhang; Ronald Rose; Steve Weinheimer; Richard J Colonno
Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Yamanaka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Hsu-Tso Ho; Li Fan; Beata Nowicka-Sans; Brian McAuliffe; Chang-Ben Li; Gregory Yamanaka; Nannan Zhou; Hua Fang; ira dicker; Richard A Dalterio; Yi-Fei Gong; Tao Wang; Zhiwei Yin; Yasutsugu Ueda; John Matiskella; John F Kadow; Paul Clapham; James Robinson; Richard J Colonno; Pin-Fang Lin
Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
Journal of virology 2006;80(8):4017-25.
2003: Pin-Fang Lin; Wade S Blair; Tao Wang; Timothy P Spicer; Qi Guo; Nannan Zhou; Yi-Fei Gong; Hwei-Gene Heidi Wang; Ronald Rose; Gregory Yamanaka; Brett Robinson; Chang-Ben Li; Robert Fridell; Carol Deminie; Gwendeline Demers; Zheng Yang; Lisa Zadjura; Nicholas A Meanwell; Richard J Colonno
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):11013-8.
2002: S Levine; Dennis Hernandez; Gregory Yamanaka; Sharon Zhang; Ronald Rose; Steve Weinheimer; Richard J Colonno
Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro.
Antimicrobial agents and chemotherapy 2002;46(8):2525-32.
1999: KM Koslowski; PR Shaver; JT Casey; T Wilson; Gregory Yamanaka; AK Sheaffer; Daniel J Tenney; NE Pederson
Physical and functional interactions between the herpes simplex virus UL15 and UL28 DNA cleavage and packaging proteins.
Journal of virology 1999;73(2):1704-7.
1999: Gregory Yamanaka; T Wilson; SF Innaimo; Gregory S Bisacchi; P Egli; J K Rinehart; Robert Zahler; Richard J Colonno
Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus.
Antimicrobial agents and chemotherapy 1999;43(1):190-3.
1997: Daniel J Tenney; Gregory Yamanaka; S M Voss; Christopher Cianci; A V Tuomari; AK Sheaffer; M Alam; Richard J Colonno
Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Antimicrobial agents and chemotherapy 1997;41(12):2680-5.
1995: Gregory Yamanaka; C L DiIanni; Donald R O'Boyle; J Stevens; Steve Weinheimer; I C Deckman; L Matusick-Kumar; Richard J Colonno
Stimulation of the herpes simplex virus type I protease by antichaeotrophic salts.
The Journal of biological chemistry 1995;270(50):30168-72.
1993: C L DiIanni; C Mapelli; D A Drier; J Tsao; S Natarajan; D Riexinger; S M Festin; M Bolgar; Gregory Yamanaka; Steve Weinheimer
In vitro activity of the herpes simplex virus type 1 protease with peptide substrates.
The Journal of biological chemistry 1993;268(34):25449-54.
1993: Steve Weinheimer; PJ McCann; Donald R O'Boyle; J T Stevens; B A Boyd; D A Drier; Gregory Yamanaka; C L DiIanni; I C Deckman; M G Cordingley
Autoproteolysis of herpes simplex virus type 1 protease releases an active catalytic domain found in intermediate capsid particles.
Journal of virology 1993;67(10):5813-22.
1992: William A Slusarchyk; Gregory S Bisacchi; A K Field; D R Hockstein; G A Jacobs; B McGeever-Rubin; J A Tino; A V Tuomari; Gregory Yamanaka; M G Young
Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds.
Journal of medicinal chemistry 1992;35(10):1799-806.
1991: Gregory Yamanaka; A V Tuomari; M Hagen; B McGeever-Rubin; B Terry; M Haffey; Gregory S Bisacchi; A K Field
Selective activity and cellular pharmacology of (1R-1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine in herpesvirus-infected cells.
Molecular pharmacology 1991;40(3):446-53.